Reid Huber
Impact in
- Oncology top 5%
- Peptidase Inhibition and Analysis
- Immunology top 5%
Papers in
-
- Kruppel-like factors research 5
- Cancer-related gene regulation 4
- Epigenetics and DNA Methylation 3
- Genetics 6
- Genetic Syndromes and Imprinting 8
- Myeloproliferative Neoplasms: Diagnosis and Treatment 3
- Chronic Lymphocytic Leukemia Research 3
- Co-authors
- Jacob E. Lemieux (1 shared paper)Sarah Slaymaker (1 shared paper)Israel F. Charo (1 shared paper)Kris Vaddi (1 shared paper)Anthony W. Ferrante (1 shared paper)Rudolph L. Leibel (1 shared paper)Deborah Hunter (1 shared paper)Stuart Phillip Weisberg (1 shared paper)
- Journals
- Gene (3 papers)PLoS ONE (2 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)Proceedings of the National Academy of Sciences (2 papers)Blood (2 papers)
- Partner nations
- United StatesItalyGermany
In The Last Decade
Reid Huber
37 papers receiving 4.4k citations
Reid Huber's Hit Papers
Peers
Comparison fields: 5 of 118
- Oncology 838
- Immunology 611
- Epidemiology 945
- Endocrinology, Diabetes and Metabolism 452
- Molecular Biology 1.9k
Countries citing papers authored by Reid Huber
This map shows the geographic impact of Reid Huber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reid Huber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reid Huber more than expected).
Fields of papers citing papers by Reid Huber
This network shows the impact of papers produced by Reid Huber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reid Huber. The network helps show where Reid Huber may publish in the future.
Co-authors
The 25 scholars most cited alongside Reid Huber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | CCR2 modulates inflammatory and metabolic effects of high-fat feeding Hit paper breakdown → | 2005 | 1316 |
| 2 | 1996 | 661 | |
| 3 | 2010 | 273 | |
| 4 | 2002 | 176 | |
| 5 | 2005 | 163 | |
| 6 | Frequent silencing of the GPC3 gene in ovarian cancer cell lines. | 1999 | 157 |
| 7 | 2006 | 152 | |
| 8 | 2015 | 146 | |
| 9 | 2020 | 145 | |
| 10 | 1994 | 137 | |
| 11 | 2000 | 102 | |
| 12 | 2005 | 97 | |
| 13 | 2000 | 95 | |
| 14 | 2002 | 93 | |
| 15 | 2021 | 89 | |
| 16 | 2002 | 82 | |
| 17 | 2010 | 69 | |
| 18 | 1996 | 65 | |
| 19 | 2021 | 58 | |
| 20 | 2010 | 50 |
About Reid Huber
Reid Huber is a scholar working on Molecular Biology, Genetics, Oncology, Genetics and Hematology, having authored 38 papers that have together received 4.5k indexed citations. Recurring topics across this work include Genetic Syndromes and Imprinting (8 papers), Kruppel-like factors research (5 papers), Cancer-related gene regulation (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Hormonal Regulation and Hypertension (3 papers), Cytokine Signaling Pathways and Interactions (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Oncology (838 citations), Immunology (611 citations), Epidemiology (945 citations), Endocrinology, Diabetes and Metabolism (452 citations) and Molecular Biology (1.9k citations). Reid Huber has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include Jacob E. Lemieux, Sarah Slaymaker, Israel F. Charo, Kris Vaddi, Anthony W. Ferrante, Rudolph L. Leibel, Deborah Hunter, Stuart Phillip Weisberg, David Schlessinger and Giuseppe Pilia. Their work appears in journals such as Gene, PLoS ONE, Journal of Pharmacology and Experimental Therapeutics, Proceedings of the National Academy of Sciences and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.